Accumulated

Additional

Other

Common Stock

Paid-in

Retained

Comprehensive

Shares

Amount

Capital

Deficit

Loss

Balance at June 14, 2026

33,068,845

$

331

$

841

$

(3,977,546

)

$

(6,057

)

Net income

—

—

—

152,179

—

Dividends declared on common stock and equivalents
($1.99 per share)

—

—

—

(65,729

)

—

Issuance and cancellation of stock awards, net

15,656

—

—

—

—

Tax payments for restricted stock upon vesting

(4,289

)

—

(1,341

)

—

—

Purchases of common stock

(216,282

)

(2

)

(15,047

)

(59,277

)

—

Exercise of stock options

30,803

—

6,227

—

—

Non-cash equity-based compensation expense

—

—

9,697

—

—

Currency translation adjustment

—

—

—

—

626

Balance at September 6, 2026

32,894,733

$

329

$

377

$

(3,950,373

)

$

(5,431

)

Accumulated

Additional

Other

Common Stock

Paid-in

Retained

Comprehensive

Shares

Amount

Capital

Deficit

Loss

Balance at December 28, 2025

33,627,992

$

336

$

1,910

$

(3,898,622

)

$

(4,766

)

Net income

—

—

—

427,740

—

Dividends declared on common stock and equivalents
($5.97 per share)

—

—

—

(199,169

)

—

Issuance and cancellation of stock awards, net

108,524

1

—

—

—

Tax payments for restricted stock upon vesting

(36,789

)

—

(1,646

)

(12,558

)

—

Purchases of common stock

(848,503

)

(8

)

(39,935

)

(267,764

)

—

Exercise of stock options

43,509

—

9,205

—

—

Non-cash equity-based compensation expense

—

—

30,843

—

—

Currency translation adjustment

—

—

—

—

(665

)

Balance at September 6, 2026

32,894,733

$

329

$

377

$

(3,950,373

)

$

(5,431

)

Accumulated

Additional

Other

Common Stock

Paid-in

Retained

Comprehensive

Shares

Amount

Capital

Deficit

Loss

Balance at June 15, 2025

33,937,222

$

339

$

843

$

(3,971,182

)

$

(4,627

)

Net income

—

—

—

139,319

—

Dividends declared on common stock and equivalents
($1.74 per share)

—

—

—

(59,184

)

—

Issuance and cancellation of stock awards, net

17,498

1

—

—

—

Tax payments for restricted stock upon vesting

(5,287

)

—

(2,390

)

—

—

Purchases of common stock

(165,778

)

(2

)

(8,722

)

(66,624

)

—

Exercise of stock options

1,490

—

563

—

—

Non-cash equity-based compensation expense

—

—

10,325

—

—

Currency translation adjustment

—

—

—

—

(618

)

Balance at September 7, 2025

33,785,145

$

338

$

619

$

(3,957,671

)

$

(5,245

)

Accumulated

Additional

Other

Common Stock

Paid-in

Retained

Comprehensive

Shares

Amount

Capital

Deficit

Loss

Balance at December 29, 2024

34,281,927

$

343

$

1,272

$

(3,956,474

)

$

(7,432

)

Net income

—

—

—

420,061

—

Dividends declared on common stock and equivalents
($5.22 per share)

—

—

—

(178,441

)

—

Issuance and cancellation of stock awards, net

75,668

1

—

—

—

Tax payments for restricted stock upon vesting

(24,590

)

—

(10,862

)

—

—

Purchases of common stock

(596,754

)

(6

)

(34,354

)

(242,817

)

—

Exercise of stock options

48,894

—

12,882

—

—

Non-cash equity-based compensation expense

—

—

31,681

—

—

Currency translation adjustment

—

—

—

—

2,187

Balance at September 7, 2025

33,785,145

$

338

$

619

$

(3,957,671

)

$

(5,245

)